Design, Synthesis, Α-Glucosidase Inhibition, Pharmacokinetic, and Cytotoxic Studies of New Indole-Carbohydrazide-Phenoxy-N-Phenylacetamide Derivatives

Design, Synthesis, Α-Glucosidase Inhibition, Pharmacokinetic, and Cytotoxic Studies of New Indole-Carbohydrazide-Phenoxy-N-Phenylacetamide Derivatives Publisher Pubmed

Hamedifar H^{1, 2} ; Mohammadikhanaposhtani M³ ; Sherafati M⁴ ; Noori M⁴ ; Moazam A⁴ ; Hosseini S⁵ ; Larijani B⁴ ; Hajimiri MH^{1, 2} ; Mahdavi M⁴ ; Erdogan MK⁶ ; Gundogdu R⁶ ; Kirici M⁶ ; Taslimi P⁷ ; Gulcin I⁸

Show Affiliations

1. CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran
2. CinnaGen Research and Production Co., Alborz, Iran
3. Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
5. Shahid Beheshti University of Medical Sciences, Tehran, Iran
6. Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Bingol University, Bingol, Turkey
7. Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Turkey
8. Department of Chemistry, Faculty of Science, Ataturk University, Erzurum, Turkey

Source: Archiv der Pharmazie Published:2023

Abstract

A new series of indole-carbohydrazide-phenoxy-N-phenylacetamide derivatives 7a–l were designed, synthesized, and screened for their α-glucosidase inhibitory abilities and cytotoxic effects. The results obtained in the α-glucosidase inhibition assay indicated that most of the synthesized derivatives displayed good to moderate inhibitory abilities (Ki values ranging from 14.65 ± 2.54 to 37.466 ± 6.46 μM) when compared with the standard drug acarbose (Ki = 42.38 ± 5.73 μM). Among them, 2-mehoxy-phenoxy derivatives 7l and 7h with 4-nitro and 4-chloro substituents on the phenyl ring of the N-phenylacetamide moiety, respectively, displayed the most inhibition effects. The inhibitory mechanism of these compounds was investigated by molecular docking studies. The in vitro cytotoxicity assay showed that only one compound, 2-methoxy-phenoxy derivative 7k with a 4-bromo substituent on the phenyl ring of the N-phenylacetamide moiety, exhibited moderate cytotoxicity against the human non-small-cell lung cancer cell line A549 and the rest of the compounds show almost no cytotoxicity. Further cytotoxic evaluations were also performed on compound 7k. The in silico pharmacokinetic study predicted that the selected compounds 7l and 7h are likely to be orally active. © 2023 Deutsche Pharmazeutische Gesellschaft.

Style	Citing Format
MLA	Hamedifar H, et al.. "Design, Synthesis, Α-Glucosidase Inhibition, Pharmacokinetic, and Cytotoxic Studies of New Indole-Carbohydrazide-Phenoxy-N-Phenylacetamide Derivatives." Archiv der Pharmazie, vol. 356, no. 6, 2023, pp. -.
APA	Hamedifar H, Mohammadikhanaposhtani M, Sherafati M, Noori M, Moazam A, Hosseini S, Larijani B, Hajimiri MH, Mahdavi M, Erdogan MK, Gundogdu R, Kirici M, Taslimi P, Gulcin I (2023). Design, Synthesis, Α-Glucosidase Inhibition, Pharmacokinetic, and Cytotoxic Studies of New Indole-Carbohydrazide-Phenoxy-N-Phenylacetamide Derivatives. Archiv der Pharmazie, 356(6), -.
Chicago	Hamedifar H, Mohammadikhanaposhtani M, Sherafati M, Noori M, Moazam A, Hosseini S, Larijani B, et al.. "Design, Synthesis, Α-Glucosidase Inhibition, Pharmacokinetic, and Cytotoxic Studies of New Indole-Carbohydrazide-Phenoxy-N-Phenylacetamide Derivatives." Archiv der Pharmazie 356, no. 6 (2023): -.
Harvard	Hamedifar H et al. (2023) 'Design, Synthesis, Α-Glucosidase Inhibition, Pharmacokinetic, and Cytotoxic Studies of New Indole-Carbohydrazide-Phenoxy-N-Phenylacetamide Derivatives', Archiv der Pharmazie, 356(6), pp. -.
Vancouver	Hamedifar H, Mohammadikhanaposhtani M, Sherafati M, Noori M, Moazam A, Hosseini S, et al.. Design, Synthesis, Α-Glucosidase Inhibition, Pharmacokinetic, and Cytotoxic Studies of New Indole-Carbohydrazide-Phenoxy-N-Phenylacetamide Derivatives. Archiv der Pharmazie. 2023;356(6):-.
BibTex	@article{ author = {Hamedifar H and Mohammadikhanaposhtani M and Sherafati M and Noori M and Moazam A and Hosseini S and Larijani B and Hajimiri MH and Mahdavi M and Erdogan MK and Gundogdu R and Kirici M and Taslimi P and Gulcin I}, title = {Design, Synthesis, Α-Glucosidase Inhibition, Pharmacokinetic, and Cytotoxic Studies of New Indole-Carbohydrazide-Phenoxy-N-Phenylacetamide Derivatives}, journal = {Archiv der Pharmazie}, volume = {356}, number = {6}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Hamedifar H AU - Mohammadikhanaposhtani M AU - Sherafati M AU - Noori M AU - Moazam A AU - Hosseini S AU - Larijani B AU - Hajimiri MH AU - Mahdavi M AU - Erdogan MK AU - Gundogdu R AU - Kirici M AU - Taslimi P AU - Gulcin I TI - Design, Synthesis, Α-Glucosidase Inhibition, Pharmacokinetic, and Cytotoxic Studies of New Indole-Carbohydrazide-Phenoxy-N-Phenylacetamide Derivatives JO - Archiv der Pharmazie VL - 356 IS - 6 SP - EP - PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract